Search
Advanced search
Filter by category
Filter by committee
Search results
-
ASTM International and the Parenteral Drug Association recently signed a Memorandum of Understanding that launches a pilot to streamline efforts and conserve resources as both organizations develop technical guidance for the pharmaceutical industry. Katharine Morgan, executive vice president, ASTM, and Richard M. Johnson, president, PDA, signed the MOU. “The MOU between ASTM International and PDA…, ASTM Committee E55 on Manufacture of Pharmaceutical Products Next Meeting:, April 28-30, 2015, Lisbon, Portugal, Media Inquiries:, Nathan Osburn, tel +1.610.832.9603; nosburn@astm.org, ASTM Staff Contact:, Christine DeJong, tel +1.610.832.9736; cdejong@astm.org Release #9815 ###
-
Keeping birds away from potentially fatal encounters with building exteriors is the purpose of a proposed new ASTM International standard, ASTM WK47853 , Test Method for Bird Collision Deterrence Material Threat Factor. It is possible that as many as a billion birds are killed every year after colliding with glass on buildings, including many single-family homes — and this is in the United States…, ASTM Committee C14 Next Meeting:, April 14, 2015, Moorestown, N.J., Technical Contact:, Stefan Knust, Ennead Architects, New York, New York, tel +1.212.807.7171; sknust@ennead.com, ASTM Staff Contact:, Thomas O’Toole, tel +1.610.832.9739; totoole@astm.org, ASTM PR Contact:, Barbara Schindler, tel +1.610.832.9603; bschindl@astm.org Release #9767
-
ASTM International Committee E55 on Manufacture of Pharmaceutical Products is currently developing a proposed standard that will document a set of process steps that can reproducibly inactivate or remove any potential retrovirus in new biological products, particularly antibodies and antibody-like compounds. The proposed standard, ASTM WK39883 , Practice for Process of Inactivation of Enveloped…, ASTM Committee E55 Next Meeting:, April 9-11, 2013, Genzyme-A Sanofi Company, Haverhill, Suffolk, United Kingdom, Technical Contact:, John Schreffler, Ph.D., Morphotek Inc., Exton, Pa., Phone: 610-423-6557; jschreffler@morphotek.com, ASTM Staff Contact:, Christine DeJong, Phone: 610-832-9736; cdejong@astm.org, ASTM PR Contact:, Barbara Schindler, Phone: 610-832-9603; bschindl@astm.org Release #9327
-
A proposed new ASTM International standard will provide an important process step to be used in the manufacture of protein-based drugs, such as antibodies and fusion proteins, made to inactivate retroviruses. The proposed standard, ASTM WK36552 , Practice for Inactivation of Retrovirus by pH, is being developed by Subcommittee E55.04 on General Biopharmaceutical Standards , part of ASTM…
-
A proposed new standard being developed by ASTM International Committee F30 on Emergency Medical Services will be useful to medical equipment manufacturers, certification agencies and care providers, with patients being the ultimate beneficiaries. The proposed new standard, ASTM WK27973 , Specification for Environmental Performance of Medical Equipment for Use on Fixed and Rotary-Wing Aircraft,…, Technical Contact:, Pete Chambers, Marketing Assessment Inc., Phone: 703-673-9003; pete@marketingassessment.com, ASTM Staff Contact:, Scott Orthey, Phone: 610-832-9730; sorthey@astm.org, ASTM PR Contact:, Barbara Schindler, Phone: 610-832-9603; bschindl@astm.org Release #8671/Sept2010
-
ASTM International Committee F08 on Sports Equipment and Facilities is focusing on elliptical equipment in its two latest approved standards. Both F2810, Specification for Elliptical Trainers, and ASTM F2811 , Test Methods for Evaluating Design and Performance Characteristics of Elliptical Trainers, are under the jurisdiction of Subcommittee F08.30 on Fitness Products. Harvey Voris, vice…, ASTM Committee F08 Next Meeting:, Nov. 16-19, November Committee Week, San Antonio, Texas, Technical Contact:, Harvey Voris, Paramount Fitness Corp., Los Angeles, Calif., Phone: 323-721-2121; hvoris@paramountfitness.com, ASTM Staff Contact:, Christine Basile, Phone: 610-832-9728; cbasile@astm.org, ASTM PR Contact:, Barbara Schindler, Phone: 610-832-9603; bschindl@astm.org Release #8672/Sept2010
-
Mass casualty events, including both natural disasters and man-made events, subject caregivers, patients and medical equipment to environmental extremes. A new standard being developed by ASTM International Committee F30 on Emergency Medical Services provides guidance for how medical equipment is expected to perform under the severe conditions of a mass casualty event. The proposed standard, ASTM…
-
While the continuous quality verification concept is still quite new, it has the potential to become an important approach to assuring product quality in the pharmaceutical industry. With this in mind, ASTM International Committee E55 on Manufacture of Pharmaceutical Products has approved a new standard, E2537 , Guide for Application of Continuous Quality Verification to Pharmaceutical and…
-
ASTM International Committee E55 on Manufacture of Pharmaceutical Products has developed a new standard that covers the life cycle of pharmaceutical and biopharmaceutical manufacturing systems. The new standard, E 2500 , Guide for Specification, Design and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment, is under the jurisdiction of Subcommittee E55.03 on…
-
A new ASTM International standard describes a variety of methods that can be used to determine the index of refraction and dispersion of glass. The standard, C 1648 , Guide for Choosing a Method for Determining the Index of Refraction and Dispersion of Glass, will be useful to manufacturers of glass and glass products as well as designers of products in which glass is a critical component. C 1648…